APOE and Alzheimer disease: Here, we show that early synergistic pathogenic effects between APOE4 and Aβ during the preclinical stages of AD—with incipient AD-related pathological changes and preserved cognition—emerge predominantly within neuronal populations, including inhibitory interneurons and excitatory neurons, rather than in glial cells, which tend to respond to either pathogen additively.